MSLN and ovarian carcinoma: Thus, the collective findings of these investigations indicate that MSLN-CAR NK cells may be effectively employed to eliminate tumor cells, delay ovarian cancer development in vivo and in vitro, and extend the survival of tumor bearing mice.